Maintaining a high degree of cardiorespiratory fitness (CRF) appears to be one way to reach old age without developing ...

The findings sparked a debate about the merits of RCTs vs other study designs—one surgeon urged others to “read a textbook.” ...

In patients who require a valve-in-valve (ViV) transcatheter procedure for a failed aortic bioprosthesis, the choice of ...

With a mix of causes and comorbidities, type 2 MI patients do better than type 1 early on, then face worse long-term outcomes ...

The findings underscore that pregnancy is “a crucial window of opportunity to optimize cardiovascular health,” researchers ...

Median follow-up duration for patients who survived to discharge after their index admission was 618 days. Over that span, 21 ...

In top-line results, the phase III trial demonstrated a “highly clinically meaningful reduction” in 24-hour systolic BP.

MINNEAPOLIS, MN—Fewer than one-quarter of patients who have heart failure with reduced ejection (HFrEF) and no clinical ...

Keeping these factors in check and adhering to the AHA’s Life’s Essential 8, is the best way to prevent CVD, say researchers.

The exploratory, post hoc look at the trial shows curves starting to separate by month 1, supporting earlier treatment.

The 12,000-patient trial of the PCSK9 inhibitor met its primary endpoints in high-risk individuals with no prior CV events.

Patients had less clinical worsening when treated with this “wonder drug,” as one doctor called it, within a year of ...